Neuraclegenetics

Developing gene therapies using adeno associated virus technology to treat various diseases

placeSeoul, Seoul, South Korea calendar_todayFounded 2018 groups30 employees language neuraclegen.com

Registered entities

Social engagement

Social engagement: 259 social following, 8 posts in the last 12 months — below the industry typical range.

Recent activity

1 May 2026
Event
ARVO 2026
11 Feb 2026
Leadership hire
Chief Strategy Officer (CSO)
19 Jan 2026
Milestone
revenue
Coming soon